UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 29, 2020
Accession Number: 0001193125-20-255644
Submission Type: POS AM
CIK: 0001510487
Company Name: Principia Biopharma Inc.
File Number: 333-234038